Michael A. Chirigos
#146,589
Most Influential Person Now
Michael A. Chirigos's AcademicInfluence.com Rankings
Michael A. Chirigosphilosophy Degrees
Philosophy
#7918
World Rank
#11200
Historical Rank
Logic
#4953
World Rank
#6295
Historical Rank
Michael A. Chirigosbiology Degrees
Biology
#10674
World Rank
#14025
Historical Rank
Immunology
#670
World Rank
#692
Historical Rank
Download Badge
Philosophy Biology
Michael A. Chirigos's Degrees
- Doctorate Medicine Harvard University
Why Is Michael A. Chirigos Influential?
(Suggest an Edit or Addition)Michael A. Chirigos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. (1985) (294)
- Pyran copolymer as an effective adjuvant to chemotherapy against a murine leukemia and solid tumor. (1975) (281)
- Interferon: an inducer of macrophage activation by polyanions. (1977) (268)
- Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. (1978) (200)
- Uptake of tyrosine by rat brain in vivo. (1960) (154)
- Brief communication: Cure of murine leukemia with drug and interferon treatment. (1973) (108)
- Immune modulation agents and their mechanisms (1985) (104)
- Hyporesponsiveness to augmentation of murine natural killer cell activity in different anatomical compartments by multiple injections of various immunomodulators including recombinant interferons and interleukin 2. (1985) (99)
- Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations. (1978) (89)
- Immune modulation and control of neoplasia by adjuvant therapy (1978) (88)
- Augmenting agents in cancer therapy (1981) (88)
- Functional and morphologic characteristics of interferon-treated macrophages. (1978) (87)
- Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant. (1973) (85)
- Stimulation of Humoral and Cellular Antibody Formation in Mice by Poly Ir:Cr 1 (1970) (82)
- Combined chemoimmunostimulation therapy against murine leukemia. (1972) (74)
- Association of macrophage activation with antitumor activity by synthetic and biological agents. (1977) (69)
- Effects of adriamycin and cyclophosphamide treatment on induction of macrophage cytotoxic function in mice. (1979) (67)
- Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. (1985) (65)
- A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. (1991) (63)
- Direct activation in vitro of mouse peritoneal macrophages by pyran copolymer (NSC 46015). (1977) (62)
- Prevention of macrophage tumoricidal activity by agents known to increase cellular cyclic AMP. (1979) (61)
- Stress‐induced Impairment of Macrophage Tumoricidal Function (1980) (61)
- Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109). (1977) (58)
- A simple micro method for the direct determination of delta-amino (14C) levulinic acid production in murine spleen and liver homogenates. (1970) (57)
- Adjuvant treatment with levamisole in cancer: a review of experimental and clinical data. (1977) (57)
- Augmentation of specific macrophage-mediated cytotoxicity: correlations with agents which enhance antitumor resistance. (1976) (55)
- Control of neoplasia by modulation of the immune system (1977) (51)
- Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney) (1968) (49)
- Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. (1994) (46)
- Selective neutralization by antiinterferon globulin of macrophage activation by L-cell interferon, Brucella abortus ether extract, Salmonella typhimurium lipopolysaccharide, and polyanions. (1979) (41)
- Pathology of the spread of L1210 leukemia in the central nervous system of mice and effect of treatment with Cytoxan. (1962) (41)
- A simple fluorometric procedure for determining salicylic acid in biologic tissues. (1959) (40)
- STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. 3. AN IN VIVO ASSAY FOR ANTI-VIRAL AGENTS. (1964) (40)
- Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo. (1980) (40)
- Cell line derived from a murine sarcoma virus (Moloney Pseudotype)-induced tumor: cultural, antigenic, and virological properties. (1971) (39)
- Virulence of Six Strains of Mycobacterium bovis (BCG) in Mice (1973) (39)
- Effective antiviral therapy of two murine leukemias with an interferon‐inducing synthetic carboxylate copolymer (1969) (37)
- Effects of whole body X-irradiation and cyclophosphamide treatment on induction of macrophage tumoricidal function in mice. (1978) (37)
- Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose. (1985) (37)
- Effect of dose and route of Bacillus Calmette-Guérin in chemoimmunostimulation therapy of a murine leukemia. (1973) (36)
- In vitro stimulation of spleen cell cultures by poly I: poly C and levamisole. (1974) (34)
- Transforming potential of the anticancer drug adriamycin. (1975) (34)
- Lymphokines and thymic hormones : their potential utilization in cancer therapeutics (1981) (33)
- Prolongation of chemotherapeutically induced remission of a syneneic murine leukemia by L-2,3,5,6-tetrahydro-6-phenylimidazo[2.1-BETA]thiazole hydrochloride. (1975) (33)
- Further studies on the homograft response in BALB/c mice with L1210 leukemia and a resistant subline. (1962) (32)
- Inhibition of DNA polymerase of avian myeloblastosis virus by an alkaloid extract from Narcissus tazetta L. (1973) (32)
- ANTIVIRAL CHEMOTHERAPEUTIC ASSAY WITH FRIEND LEUKEMIA VIRUS IN MICE. (1965) (31)
- Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC]. (1981) (31)
- Role of E-type prostaglandins in the regulation of interferon-treated macrophage cytotoxic activity. (1979) (30)
- Factors affecting macrophage cytotoxic activity with particular emphasis on corticosteroids and acute stress. (1979) (30)
- Combined drug and immunostimulation therapy against a syngeneic murine leukemia. (1974) (30)
- Antiproliferative activity of picolinic acid due to macrophage activation. (1987) (30)
- Inhibition of murine sarcoma virus oncogenesis with living BCG (1971) (29)
- Studies with the murine leukemogenic Rauscher virus. I. Chemotherapy studies with in vivo and in vitro assay systems. (1963) (28)
- Radioprotection by biological response modifiers alone and in combination with WR-2721. (1988) (28)
- Inhibition of RNA-dependent DNA polymerase of avian myeloblastosis virus by pyran copolymer. (1974) (27)
- Antigenic and Biochemical Characterization of the C-type Particle of the Stable Porcine Kidney Cell Line PK-15 (1973) (27)
- Response of a virus-induced murine lymphoid leukemia to drug therapy. (1961) (27)
- Enhanced macrophage and natural killer cell antitumor activity by various molecular weight maleic anhydride divinyl ethers. (1980) (26)
- Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum. (1969) (26)
- Some aspects of host response to levamisole after chemotherapy in a murine leukemia. (1975) (26)
- Stimulation and inhibition of neoplastic cell growth by tumor promoter-treated macrophages. (1980) (25)
- Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium. (1984) (25)
- EXPERIMENTS ON DETERMINATION OF MELPHALAN BY FLUORESCENCE. INTERACTION WITH PROTEIN AND VARIOUS SOLUTIONS. (1964) (25)
- Effect of streptonigrin (NSC-45383) and analogs on oncornavirus replication and DNA polymerase activity. (1973) (23)
- STIMULATION OF AROMATIC AMINO ACID TRANSPORT BY P-FLUOROPHENYLALANINE IN THE SARCOMA 37 CELL. (1964) (23)
- Increased oncogenicity of the murine sarcoma virus (Moloney) by co-infection with murine leukemia viruses. (1968) (22)
- Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement. (1976) (21)
- Duration effective levels of three antitumor drugs in mice with leukemia L1210 implanted intracerebrally and subcutaneously. (1965) (21)
- Immunomodulators: current and future development and application. (1992) (21)
- Adenosine deaminase inhibition for immunosuppression. (1977) (20)
- In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA). (1984) (20)
- Macrophage activation for nonspecific tumor cytotoxicity. (1980) (20)
- Mediation of cellular immunity in cancer by immune modifiers (1981) (20)
- REGULATION OF MACROPHAGE TUMORICIDAL FUNCTION- A ROLE FOR PROSTAGLANDINS OF THE E SERIES (1979) (19)
- Macrophage involvement in the antitumor activity of Brucella abortus ether extract against experimental lung carcinoma metastases. (1978) (19)
- Effect of Levamisole on the In Vitro Immune Response of Spleen Lymphocytes (1975) (19)
- Studies on the disposition of actinomycin D-3H in virus-infected and tumor-bearing mice. (1966) (19)
- Cell-Based and Biochemical Analysis of the anti-HIV Activity of Combinations of 3′-azido-3′-deoxythymidine and Analogues of TIBO (1994) (19)
- Studies on the suppression of the homograft response with folic acid antagonists. (1961) (18)
- Immunity of Mice Surviving Systemic Leukæmia (L1210) to Antifolic Resistant Variants of the Disease (1960) (18)
- Role of prostaglandin E and interferon in secretion of colony-stimulating factor by murine macrophages after in vitro treatment with biological response modifiers. (1984) (18)
- Survey of newer biological response modifiers for possible use in radioprotection. (1988) (17)
- Chemical and biological adjuvants capable of potentiating tumor cell vaccine. (1978) (17)
- STUDIES WITH THE MURINE LEUKEMOGENIC RAUSCHER VIRUS. II. CHEMOTHERAPY OF VIRUS-INDUCED LYMPHOID LEUKEMIA. (1963) (17)
- Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function. (1978) (17)
- Specific potentiation of L1210 vaccine by pyran copolymer. (1976) (17)
- The immunomodulatory effect on BM 12.531 (azimexon) on normal or tumored mice: in vitro and in vivo studies. (1980) (17)
- Differential antiviral activity of two TIBO derivatives against the human immunodeficiency and murine leukemia viruses alone and in combination with other anti-HIV agents. (1993) (17)
- Potentiation of Murine Sarcoma Virus (Harvey) (Moloney) Oncogenicity in Lactic Dehydrogenase-Elevating Virus-Infected Mice (1971) (16)
- Secretion of Colony‐Stimulating Factors by Human Monocytes and Bone Marrow Cells After In Vitro Treatment With Biological Response Modifiers (1985) (16)
- Effect of three strains of BCG against a murine leukemia after drug therapy. (1973) (16)
- Effectiveness of Cytoxan against intracerebrally and subcutaneously inoculated mouse lymphoid leukemia L1210. (1962) (16)
- Effects of amino acids, analogs, and certain other agents in relation to tyrosine transport in sarcoma 37 ascites cells. (1962) (16)
- Dose responsiveness and variation among inbred strains of mice in production of interferon after treatment with poly (I)-poly (C) (poly-D-lysine) complexes. (1971) (16)
- Detection in colorectal carcinoma patients of antibody cytotoxic to established cell strains derived from carcinoma of the human colon and rectum (1975) (16)
- Enhancement by poly-D-lysine of poly I: C-induced interferon production in mice. (1970) (16)
- Development of hyporesponsiveness to augmentation of natural killer cell activity after multiple doses of maleic anhydride divinyl ether: association with decreased numbers of large granular lymphocytes. (1985) (16)
- Characterization of the promoter for the rat and human link protein gene. (1991) (15)
- Immunosuppressive activity of human chorionic gonadotrophin preparations in vivo: evidence for gonadal dependence. (1983) (15)
- Development of hyporesponsiveness of natural killer cells to augmentation of activity after multiple treatments with biological response modifiers (2004) (15)
- Augmentation of therapeutic efficacy of 3',5'-dichloromethopterin against an antifolic-resistant variant of leukemia (L1210-M46R) in mice. (1960) (14)
- Antiviral efficacy of Imexon in the Rauscher murine retrovirus AIDS model. (1990) (14)
- Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities. (1984) (14)
- Therapy of peritoneal murine cancer with biological response modifiers. (1985) (14)
- Levamisole inhibition of microsomal lipid peroxidation as related to its sulfhydryl metabolite dl-2-oxo-3-(2-mercaptoethyl)-5-phenylimadazolidine. (1980) (13)
- Effect of crude and purified human chorionic gonadotropin on murine delayed-type hypersensitivity: a role for prostaglandins. (1982) (13)
- Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi. (2005) (13)
- Biological interrelationships in the chemotherapy of Moloney virus leukemia. (1963) (13)
- Protection of rat liver microsomes from NADPH-, ascorbate-, and X-irradiation-induced lipid peroxidation by levamisole. (1979) (13)
- DIVEMA-methotrexate: immune-adjuvant role of polymeric carriers linked to antitumor agents. (1978) (12)
- Erythropoietic responses of mice to infection with Rauscher leukemia virus. (1972) (12)
- Evaluation of surgery and chemotherapy in the treatment of mouse mammary adenocarcinoma 755. (1962) (12)
- THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT. (1964) (12)
- Characterization of Agents (1983) (12)
- Drug therapy against a transplantable guinea pig leukemia. (1975) (11)
- Plasma lactate dehydrogenase and spleen heme biosynthetic activity following Friend and Rauscher leukemia virus infections. (1967) (11)
- Geldanamycin Inhibition of 3-Methylcholanthrene-lnduced Rat Embryo Cell Transformation 1 (1977) (11)
- Effectiveness of Therapy with a Multistranded Synthetic Polynucleotide Complex Against a Murine Sarcoma Virus (1969) (11)
- UTILITY OF LEUKEMOGENIC VIRUSES FOR TESTING ANTIVIRAL AGENTS IN VIVO (1965) (11)
- Effect of alkylating agents on meningeal leukemia L1210 arising in methotrexate-treated mice. (1966) (11)
- Prostaglandin E synthesis and release by murine macrophages and human monocytes after in vitro treatment with biological response modifiers. (1983) (11)
- Effect of imexon treatment on Friend virus complex infection using genetically defined mice as a model for HIV-1 infection. (1991) (11)
- AM3, an adjuvant to hepatitis B revaccination in non-responder healthy persons. (1995) (10)
- In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide. (1985) (10)
- Enhancement of a tumor allograft in BALB/c x DBA/2 F1 mice by pyran copolymer. (1976) (10)
- Enhancement of Friend and Rauscher leukemia virus replication in mice by Guaroa virus. (1968) (10)
- Intracerebral Growth and Treatment of Leukemia L1210 (1960) (10)
- Immunomodulation and therapeutic characterization of thymosin fraction five (2004) (9)
- Biologic-response modifiers and adjuvant chemotherapy: consideration of selected preclinical investigations in relation to clinical potential. (1982) (9)
- Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC. (1984) (9)
- Histological and combined chemoimmunostimulation therapy studies against a murine leukemia (1975) (9)
- Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by tilorone (NSC-143969) and its analogs. (1974) (9)
- Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus. (1969) (9)
- 3'-Iodo-4-amino-4-deoxypteroylglutamic Acid (3'-Iodoaminopterin) (1965) (9)
- Friend leukemia virus spleen focus assay: relationship of spleen foci to viremia, splenomegaly, and survival time. (1967) (9)
- Cytotoxic activity of interferon-treated macrophages studied by various inhibitors. (1978) (8)
- Animal models in cancer research which could be useful in studies of the effect of alcohol on cellular immunity. (1979) (8)
- Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication. (1970) (8)
- Immunological and Tumor Responses to Various Immunotherapeutic Agents (1981) (8)
- Cell and tissue distribution of 14C-labeled pyran copolymer. (1978) (7)
- Immunological and chemotherapeutic prevention and control of oncogenic viruses. (1975) (7)
- Macrophage activation and antitumor activity of a Brucella abortus ether extract, Bru-Pel. (1978) (7)
- Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types. (1979) (7)
- "The immunological orchestra in cancer". (1979) (7)
- Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers. (1985) (7)
- Enhancing activity of various immunoaugmenting agents on the delayed-type hypersensitivity response in mice. (1982) (7)
- Immunoregulatory biological response modifiers: effect of cytokines on septic shock (1993) (6)
- Differential response of Friend leukemia virus and lactate dehydrogenase virus to chemotherapy and in vitro neutralization. (1968) (6)
- Effect of levamisole (NSC-177023) on DNA synthesis by lymphocytes from immunosuppressed C57BL mice. (1975) (6)
- Immune modulation and cancer control. (1978) (6)
- Streptonigrin Inhibition of 3-Methylcholanthrene Transformation in Vitro 1 (1974) (6)
- Fluorescence of the fluorinated phenylalanines. (1962) (6)
- Cell regulatory and immunorestorative activity of picibanil (OK432). (1987) (6)
- Effect of Friend leukemia virus infection upon polycythemia and delta-aminolevulinic acid synthetase activity in nurine spleen and liver. (1969) (5)
- Effect of macrophage activation by immunoadjuvants on serum levels of lysosomal hydrolases in mice. (1979) (5)
- Immunotherapy of lung cancer (1979) (5)
- Comparison of in vitro and in vivo modulation of myelopoiesis by biological response modifiers (2004) (5)
- Immunosuppression by Murine Sarcoma Virus (Moloney) (1970) (5)
- In vivo therapy of oncogenic viruses. (1969) (5)
- A comparison by several techniques of the antibody prepared in various species against the Rauscher murine leukemia virus. (1966) (5)
- The effect of drug therapy against a histologically defined rat leukemia. (1974) (5)
- Protection of avian myeloblastosis virus (AMV) DNA polymerase by substrates against heat inactivation. (1974) (5)
- Dose Responsiveness and Variation Among Inbred Strains of Mice in Production of Interferon After Treatment with Poly (I)· Poly (C) [Poly-d-Lysine] Complexes (1971) (4)
- Report of the symposium on the use of intravenous gammaglobulin in adults infected with the human immunodeficiency virus (1990) (4)
- Effective Immunotherapy of Friend Virus Infection.∗ (1967) (4)
- [Hepatitis B virus and the inflammatory/immunologic response (II): a new opportunity for the treatment of chronic hepatitis B and a suggestion for the treatment of other persistent viral diseases]. (1998) (4)
- Drepression of nuclear template restrictions for DNA synthesis by the immunostimulator pyran copolymer. (1978) (4)
- The Characterization of Immunotherapeutic Agents (1990) (4)
- Imexon and biological response modifiers in murine models of AIDS. (1991) (4)
- Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2 (2004) (4)
- Regulation of Prostaglandin Synthesis by Biological Response Modifiers and Effect on Natural Killer Cells and Bone Marrow (1985) (4)
- Effects of protein depletion on NK cell cytotoxicity and bone marrow cellularity (1985) (4)
- T and B lymphocyte populations of the spleen and thymus in normal and immunosuppressed BALB/c mice. (1978) (4)
- Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly(I,C)-LC]. (1985) (4)
- Leukocyte Interleukin, Inj. (LI) augmentation of natural killer cells and cytolytic T-lymphocytes. (1995) (4)
- Studies on the enzymology of the rhabdomyosarcoma induced by the murine sarcoma virus (Moloney). (1970) (3)
- Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers (2005) (3)
- Reversal by syngeneic spleen cells of inhibitory effects of drugs and irradiation on Friend virus. (1966) (3)
- Immunotherapeutic agents: Their role in cellular immunity and their therapeutic potential (2005) (3)
- THE EFFECT OF IMMUNE MODULATORS ON THE ONCOGENIC PROCESS : ADJUVANT EFFECT OF STAPHYLOCOCCUS AUREUS IN TREATING MURINE LEUKEMIA (1976) (3)
- The modulatory effect of exogenously added prostaglandin E1 or E2 on the delayed-type hypersensitivity reaction of normal or tumored mice. (1979) (3)
- Development of Friend leukemia virus in spleen and plasma of Swiss mice. (1965) (3)
- Improved determination of β-glucuronidase in serum (1978) (3)
- Immunological properties of Friend virus from mouse spleen obtained by gel filtration. (1969) (3)
- Augmentation of cytotoxicity by splenic cells of pregnant or human chorionic gonadotropin-treated normal mice. (1980) (2)
- Lymhocyte stimulatory effect of an ether-extracted preparation of Brucella abortus. (1978) (2)
- Antimetastatic effects of maleic anhydride-divinyl ether in rats with mammary adenocarcinoma. (1983) (2)
- TIBO derivatives are potent inhibitors of HIV-1 reverse trancriptase with heteropolymer templates (1991) (2)
- Carnitine and Derivatives in Experimental Infections (1997) (2)
- Establishment and characterization of a cell line derived from a spontaneous murine lung carcinoma (M109). (1977) (2)
- Friend Leukemogenic Virus-neutralizing Antibody from Mouse Ascitic Fluid. (1967) (2)
- Use of a murine sarcoma virus in an in vivo assay for antiviral and antitumor agents. (1970) (2)
- Growth response of the confused flour beetle, Tribolium confusum (Duval) to six selected protein sources. (1960) (2)
- Cell Line Derived from a Murine Sarcoma Virus (Moloney Pseudotype)-Induced Tumor: Cultural, Antigenic, and Virological Properties (1971) (2)
- Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy. (1986) (2)
- Enhanced antitumor response to combined treatment with maleic vinyl ether. (1981) (2)
- Effects of poly(I,C)-LC on growth and differentiation of normal and malignant myelopoietic progenitor cells. (1985) (2)
- CHEMOTHERAPY STUDIES WITH VIRUS-INDUCED LEUKEMIA IN MICE. (1964) (2)
- Protein deficiency reduces natural antitumor immunity. (1987) (2)
- Current studies on the therapy of experimental leukemia. (1970) (2)
- Virulence ofSixStrains ofMycobacterium bovis (BCG)inMice (1973) (2)
- Enhancement of murine sarcoma virus (Moloney) infection in mice by Guaroa virus. (1970) (1)
- Chemical regulation of immunity in veterinary medicine. Proceedings of a symposium held in Bethesda, Maryland, September 19-20, 1983. (1984) (1)
- Polysaccharides and Related Substances II (1981) (1)
- Improved determination of beta-glucuronidase in serum. (1978) (1)
- Response of Raucher virus to drug and immune serum therapy in vivo. (1966) (1)
- Enhancement by Poly-d-Lysine of Poly I: C-Induced Interferon Production in Mice (1970) (1)
- [Protein deficiency, host defense and natural anti-tumor immunity]. (1986) (1)
- Biological characterization of MVE-2 and poly ICLC. (1984) (1)
- Significant anti-HIV activity of new modified polyanionic polymers in vitro. (1992) (1)
- Current studies on oncorna virus therapy. (1973) (1)
- EXTRACTION AND FLUOROMETRIC DETERMINATION OF A TEREPHTHALANILIDE IN BIOLOGICAL TISSUES. (1963) (1)
- Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma. (1979) (1)
- Immune response by biological response modifiers. (1987) (1)
- Enhancement of Friend Leukemia Virus Infection in Mice by Guaroa Virus: Quantitation and Action of Various Oncogenic and Nononcogenic Viruses (1970) (1)
- Effect of Chemically Modified 70S RNA from Avian Myeloblastosis Virus (AMV) upon the Activity of AMV DNA Polymerase (1974) (1)
- BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice. (1973) (1)
- Effect of azimexon (BM 12.531) on mouse granulocyte-macrophage and monocyte-macrophage progenitor cells (1982) (1)
- The oncostatic effect of methyl-CCNU on various experimental lymphoreticular neoplasms. (1982) (1)
- Antitumor action of interferon: animal systems. (1981) (1)
- Synthetic Immunomodifiers (II) (1989) (1)
- Immunotherapy with allogeneic immune peritoneal cells activated by BCG or pyran copolymer (1978) (1)
- Use of glucan and other immunopharmacological agents in the prevention and treatment of acute radiation injuries. (1988) (1)
- T and B lymphocytes of irradiated, tumor-bearing mice treated with an immunostimulator, pyran. (1978) (1)
- [Hepatitis B virus (HBV) and the inflammatory/immune response. I. The natural environment of the antigen presentation and immunologic chaos induced by the virus]. (1997) (1)
- Establishment and characterization of a cell line derived from a spontaneous murinelung carcinoma (M109) (1977) (1)
- Inhibition of NK cell generation by Corynebacterium parvum. (1991) (1)
- Spontaneous murine lung carcinoma (m109). (1977) (0)
- Co-Infection ofMouse Spleen Cells withMurine Sarcoma Virus andGuaroa Virus (1972) (0)
- Effect of maleic anhydride-vinyl ether on the lymphocyte subpopulations of tumor-bearing, irradiated mice. (1978) (0)
- Transamination in transplanted and spontaneous tumors. Abstr. (1960) (0)
- Role for prostaglandins of the e-series in regulation of macrophage tumoricidal function. Abstr. (1978) (0)
- Obituary--John P. Glynn. (1971) (0)
- Elucidation of the Nature of the Murine Oncogenic Virus Inhibitor Isolated from JLS-V5 Cell Line (1971) (0)
- T and B lymphocyte populations of tumor-bearing mice treated with 1,3-bis(chloroethyl)-1-nitrosourea (BCNU) or pyran (1978) (0)
- Obituary-John V. Glynn (1971) (0)
- Studies with the IFN Inducer and Immune Modulator, Poly ICLC (1984) (0)
- Modulating activity of polyinosinic-polycytidylic acid stabilized with poly-l-lysine (poly iclc) on immune response. Abstr. (1981) (0)
- Variant of a sarcoma virus (moloney). (1968) (0)
- Enhancement of Friend leukemia virus infection in mice by Guaroa virus: quantitation and action of various oncogenic and nononcogenic viruses. (1970) (0)
- Various immunoaugmenting agents. Abstr. (1981) (0)
- Studies of Levamisole in Experimental Tumor Systems (1979) (0)
- Inhibitory effect of streptonigrin on a murine sarcoma virus-induced tumor cell line (MSC) and selection of drug-resistant clones (1973) (0)
- Chemoimmunostimulation therapy against a murine leukemia. Abstr. (1975) (0)
- Emphasis on corticosteroids and acute stress. (1979) (0)
- Friend Leukemogenic Virus-neutralizing Antibody from Mouse Ascitic Fluid (1967) (0)
- Measurement of antitumor and adjuvant effects of interferon with transplantable and other tumors in mice. (1981) (0)
- Induction of tumor-derived CSF-production by biological response modifiers (1982) (0)
- Following friend and rauscher leukemia virus infections. (1967) (0)
- Enhancement of murine sarcoma virus (moloney) oncogenicity in mice by coinfection with rauscher leukemia virus. Abstr. (1968) (0)
- Antitumor action of interferon: animal systems. (1977) (0)
- Hyporesponsiveness of Natural Killer Activity Induced in Vivo By Multiple Treatment with Maleic Acid Anhydride Divinyl Ether (MVE-2) (1984) (0)
- Effect of alkylating agents on meningeal leukemia l-1210 arising in methotrexate (mtx) treated mice. Abstr. (1964) (0)
- Splenic porphyria in mice in response to friend virus and rauscher virus infection. Abstr. (1966) (0)
- Comments on treatment of feline leukemia. (1971) (0)
- Effectiveness of cytoxan against intracerebrally (i.c.) And subcutan- eously (s.c.) Inoculated mouse lymphoid leukemia l1210. Abstr. (1961) (0)
- Effects of irradiation and cyclophosphamide (cy) treatment on expression of macrophage tumoricidal function in mice. Abstr. (1978) (0)
- Hemopoietic and survival-enhancing effects of xerosin II, ribavarin, bru-pel, and ampligen (1988) (0)
- Overview of chemicals and biologicals capable of regulating immunity. (1984) (0)
- MultidineTM Augmentation of Natural Killer Cells and Cytolytic T Lymphocytes (1995) (0)
- Abolishment of macrophage immunosuppressive properties after carrageenan treatment in pregnant mice. Abstr. (1982) (0)
- Mouse leukemia therapy, effects of bcg dose and route of administration. Abstr. (1973) (0)
- Co-Infection of Mouse Spleen Cells with Murine Sarcoma Virus and Guaroa Virus (1972) (0)
- Similarities among factor(s) which activate macrhophag@@@@es lymphokine (lk) and fibroblast-derived interferon (if) preparations. Abstr. (1977) (0)
- USING PHOTOGRAMMETRY TO ANALYZE STRUCTURES IN A TECTONIC SLIVER IN THE FOOT WALL OF THE CHAMPLAIN THRUST, SHELBURNE, VERMONT (2016) (0)
- 2001 – STUDIES OF LEVAMISOLE IN EXPERIMENTAL TUMOR SYSTEMS (1978) (0)
- MACROPHAGES AS TUMOUR GROWTH PROMOTERS? (1978) (0)
- The effect of prostaglandin E1 or E2 on the in vitro blastogenic response of lymphocytes from normal and tumor-bearing mice. (1979) (0)
- 238 Inhibitory action of drugs against intra-cerebral leukaemia (1961) (0)
- Immunological Properties of Friend Virus from Mouse Spleen Obtained by Gel Filtration (1969) (0)
- Mice treated with an immunostimulator, pyran. (1978) (0)
- Enhanced natural killer cell activity in mice resulting from pregnancy or human chorionic gonadotropin treatment. Abstr. (1980) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael A. Chirigos?
Michael A. Chirigos is affiliated with the following schools:
